REFERENCES
- Crosignani PG. Future oral contraceptive strategy in Europe. In van Lunsen RHW, Unzeitig V, Creatsas G, eds. Contraceptive Choices and Realities: Proceedings of the 5th Congress of the European Society of Contraception. Carnforth, UK: Parthenon Publishing, 2000
- Kuenssberg EV, Kay CR, Dewhurst J, Booth RJ. Recommendations from the findings of the RCGP oral contraceptive study on the mortality risks of the oral contraceptive. Br Med J 1977;2:947–8
- Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contra- ceptives: possible modifying effects of formulation and age at use. Lancet 1983; 2:1414
- Vessey MP, Lawless M, McPherson K, Yeates D. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet 1983;2:930–4
- McPherson K, Vessey MP, Neil A, Doll R, Jones L, Roberts M. Early contraceptive use and breast cancer: results of another case–control study. Br J Cancer 1987; 56:653–60
- Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept 1992; 8(Suppl 1): 13–20
- Lete I, Bermejo R, Coll C, et al. Use of contraceptive methods in Spain: results of a national survey. Contra- ception 2001;63:235–8
- Parrilla JJ, Coll C, Bajo JM, et al. Analysis of compliance with oral contraception in Spain. Eur J Contracept Reprod Health Care 1996;1:337–47
- Oddens B, Arnolds H, van Maris M, et al. The dynamics of oral contraceptive use: starting, discontinuation and switching in The Netherlands 1990–93. Adv Contracept 1994;10:167–74
- Ketting E, Schnabel P. Induced abortion in The Netherlands: a decade of experience, 1970–80. Stud Fam Plann 1980;11:385–94
- Furedi A. The public health implications of the 1995 ‘pill scare’. Hum Reprod Update 1999;5:621–6
- Sidney S, Petitti DB, Quesenberry CP, et al. Myocardial infarction in users of low-dose oral contraceptives. Obstet Gynecol 1996;88:939–44
- Galazios G, Emin M, Koutlaki N, et al. Differentiation in contraceptive behavior of the female population in Thrace, Greece. Eur J Contracept Reprod Health Care 2001;6:78–86
- World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of an international multicentre case–control study. Lancet 1995;346:1575–82
- Spitzer WO, Lewis MA, Heinemann LAJ, et al. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case- control study. Br Med J 1996;312:83–8
- Skouby SO. Oral contraceptives and venous thrombo- sis: end of the debate. Eur J Contracept Reprod Health Care 1998;3:59–64
- White E, Malone KE, Weiss N, et al. Breast cancer among young US women in relation to oral contra- ceptive use. J Natl Cancer Inst 1994;86:505–14
- Ursin G, Henderson BE, Haile RW, et al. Does oral contraceptive use increase the risk for breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 1997;57:3678–81
- Serfaty D. Medical aspects of contraceptive discon- tinuation. Adv Contracept 1992; 8(Suppl 1): 21–33
- Rosenberg M, Waugh M, Meehan T. Use and misuse of contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995;51:283–8
- Dafopoulos K, Galazios G, Tsikouras P, et al. Inter- pregnancy interval and the risk of preterm birth in Thrace-Greece. Eur J Obstet Gynecol Reprod Biol 2002; in press